GLP-1 drugmakers sued over sudden vision loss risk: Reports
A civil lawsuit has been filed against GLP-1 drugmakers over the potential risk of sudden vision loss, according…
Possibly problematic drug combos commonly prescribed to older adults
Share on PinterestA new study identifies 24 common, and potentially inappropriate, prescribing cascades that may result in medication-related…
Hundreds of lawsuits filed against some GLP-1 Makers over vision loss
Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
Australia news live: police investigating possible organised crime links after 11-year-old boy shot in Sydney apartment | Australia news
NSW police hold press conference after young boy shot in the face in Sydney unit NSW police are…
Illinois Gov. JB Pritzker says he has lost 80 pounds on ‘life-changing’ GLP-1 medication – CTV News
Illinois Gov. JB Pritzker says he has lost 80 pounds on ‘life-changing’ GLP-1 medication CTV NewsJB Pritzker Says He…
Andrographis dropped from listed medicines framework
ajp.com.au This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional…
What is ibogaine, and what does it treat?
Ibogaine, a psychoactive compound made from the roots of an African shrub, has been gaining popularity as a…
The drugs that could slow Alzheimer’s
New treatments for Alzheimer’s that significantly slow down its progression could become available through the NHS in the…
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – Yahoo Finance
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth…
Stopping Ozempic may raise heart attack and stroke risk
GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have surged in popularity for…
The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?
Morgan Stanley has cut Novo Nordisk A/S (NYSE:NVO) to Underweight on September 11, 2026. Semaglutide, the underlying molecule…
Karnataka cancels 16 licences, suspends 8 over spurious drugs: Full list
The Karnataka Food Safety and Drugs Administration (FSDA) has cancelled the licences of 16 pharmaceutical retailers and wholesalers,…